How I manage monoclonal gammopathy of undetermined significance - ScienceDirect
Frontiers | Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
A Case of Smoldering Multiple Myeloma with Simultaneous Increase of a Polyclonal Immunoglobulin
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
How to Diagnose Monoclonal Gammopathy of Undetermined Significance – Consult QD
When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
Comparison of MGUS and multiple myeloma variants | Download Table
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study - The Lancet
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Diagnosis of monoclonal gammopathy of renal significance - ScienceDirect
Multiple myeloma - The Lancet
Protein Marker Evaluation of Monoclonal Gammopathies | AACC.org
Updated Diagnostic Criteria and Staging System for Multiple Myeloma | American Society of Clinical Oncology Educational Book
UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
